The complex intervention day hospice — a quality-assured study on the implementation, realization, and benefits with model character for Germany (IMPULS) using the example of “Day hospice Adiuvantes”
Ulrich Kaiser(University of Applied Sciences Landshut), Florian Kaiser(University of Applied Sciences Landshut), Alexandra Hofbauer, Anne Benning(University Hospital Regensburg), Ana Hoffmann(University of Applied Sciences Landshut), Michael Rechenmacher(University Hospital Regensburg), Michael Koller(University Hospital Regensburg), Ursula Vehling‐Kaiser(University of Applied Sciences Landshut), Moritz Fiedler(University of Applied Sciences Landshut)
Cited by 6
Related Papers
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2014|1.7k
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer
|European Journal of Cancer|2009|452